Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/32943
Başlık: The anticancer activity of complex [Cu-2(mu-(C6H5)(2)CHCOO)(3)(bipy)(2))](ClO4) -solid lipid nanoparticles on MCF-7 cells
Yazarlar: Kani, İbrahim
Dikmen, Gökhan
Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyoloji Anabilim Dalı.
0000-0001-7904-883X
0000-0002-2088-9914
0000-0002-1619-6680
0000-0002-3820-424X
Eskiler, Gamze Güney
Çeçener, Gülşah
Tunca, Berrin
Egeli, Ünal
AAH-1420-2021
AAB-6011-2022
ABI-6078-2020
AAP-9988-2020
57190947987
6508156530
6602965754
55665145000
Anahtar kelimeler: Pharmacology & pharmacy
Bipy
Cu(II) complex
Diphenyl acetic acid
MCF-7
Metal-based ligands
Solid lipid nanoparticles(SLNs)
Copper(II) complexes
Crystal-structures
Drug-delivery
Superoxide-dismutase
Antitumor activities
DNA interaction
Caffeic acid
X-ray
Ligands
Binding
Yayın Tarihi: 1-Ara-2016
Yayıncı: Bentham Science
Atıf: Kani, İ. vd. (2016). "The anticancer activity of complex [Cu-2(mu-(C6H5)(2)CHCOO)(3)(bipy)(2))](ClO4) -solid lipid nanoparticles on MCF-7 cells". Current Drug Delivery, 13(8), 1339-1350.
Özet: Recent studies have focused on the potential use of metal-based complexes for the treatment of cancer. However, there are some limitations of metal-based ligands for the treatment of cancer due to their toxic effects. In the present study, a novel bimetallic Cu(II) complex, [Cu-2(mu-(C6H5)(2)CHCOO)(3) (bipy)(2))](ClO4), has firstly been synthesized and characterized by FT-IR, and X-ray crystallography. Furthermore, Cu(II) complex-loaded solid lipid nanoparticles (SLNs) were initially prepared by hot homogenization method to overcome their toxic effects. After characterization, comparative cytotoxic and apoptotic activities of the complex and Cu(II) complex-SLNs on human breast cancer cells (MCF-7) and human umbilical vein endothelial cells (HUVEC) were determined. Cu(II) complex demonstrated considerable in vitro cytotoxic effects on MCF-7 (p<0.05) and induced apoptotic cell death (88.02 +/- 3.95%) of MCF-7 cells. But, the complex has also toxic effects (69.5%) on HUVEC control cells. For this purpose, Cu(II) complex-loaded solid lipid nanoparticles (SLN) were firstly produced, with a distrubution range of 190 +/- 1.45 nm to 350 +/- 1.72 nm and zeta potentials of -27.4 +/- 1.98 mV and -18.2 +/- 1.07 mV, respectively. The scanning electron microscopy (SEM) images of SLNs were also obtained. In vitro studies have shown that Cu(II) complex-SLNs help in reducing the side effect of Cu(II) complex (29.9%) on HUVEC control cells. Therefore, metal based complex might potentially be used for cancer treatment through nanoparticle based drug delivery systems.
URI: https://doi.org/10.2174/1567201813666160111123739
http://www.eurekaselect.com/article/72982
https://www.ingentaconnect.com/content/ben/cdd/2016/00000013/00000008/art00013
http://hdl.handle.net/11452/32943
ISSN: 1567-2018
1875-5704
Koleksiyonlarda Görünür:Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.